Let me begin by giving insight about the Parent Organization followed by the details on Meril Life Science.

ABOUT PARENT ORGANISATION:-

Meril Life Sciences has been floated by a large Indian Multinational company which has now entered into globally successful joint ventures with two prominent German groups.

Our core businesses are-

1. Manufacturing of printing inks and

2. Manufacturing of pesticides (agro-chemicals)

Both the businesses have successful joint ventures with two prominent business groups incidentally from Germany.

* Our ink business, MicroInks has now a JV with Huber of Germany and

* Our pesticides business, Bilag has a JV with Bayer of Germany.

We have one of the world's largest inks and pyrethroid (pesticides) manufacturing plants in India.

You could visit www.bilakhiaholdings.com to see the work done so far.

Bilakhia Group in its new format has large scale exciting businesses-

* Health Care - Medical Devices

* Education - K through 12 model of education

Health Care

* Maxx Orthopedics - HQ in Philadelphia, USA. Maxx advanced Total Knee and Total Hip Replacement portfolio. www.maxxmed.com

* Meril Life Sciences - HQ in Vapi, India. Meril has advanced Coronary Stent Systems portfolio. www.merillife.com

Education

* Mexus Education - HQ in Mumbai, India. Mexus works on revitalizing education systems from kindergarten to 12th levels through highly advanced interactive media based tools. www.mexuseducation.com

ABOUT MERIL LIFE SCIENCES:-

We are based at Vapi, which is 150kms north of Mumbai in India www.merillife.com

Meril operations were started in 2007 and currently we boast of 40,000 Sq. ft. of ultra-modern manufacturing facility for Vascular stents PTCA balloon catheters. Our technology has been sourced from USA and Europe just like all our manufacturing equipments, machinery and interiors. There are more than 8,000 Sq. ft. of Class 10,000 clean rooms and all our key manufacturing activities are done under Class 100 Laminar Air Flow.

Our plant has ISO 13485 and cGMP certification. We have all processes in-house from from laser cutting of stents to manufacturing of PTCA balloon catheters including Ethylene Oxide sterilization, analytical chemistry (pK studies) and microbiological tests.

We are currently a growing team of over 175 persons (120 in manufacturing) with an average age of 27years. The team comprises of Engineers, Designers, R D Chemists, QA personnel, Regulatory and Clinical people and Marketing functions.

Our current portfolio includes Coronary stents, PTCA balloon catheters and an Inflation device.

We have an interesting portfolio of CE marked/ ANVISA approved / Indian FDA approved Coronary Stent Systems-

1. BioMime - Sirolimus Eluting Coronary Stent System (Sirolimus Eluting Biodegradable Polymer Based DES - NexGen design platform)

2. NexGen - Cobalt Chromium Coronary Stent System (Novel hybrid cell design concept)

3. Crypton - Stainless Steel Coronary Stent System (Novel hybrid cell design concept)

Apart from the above products, we have our line of work horse Rx PTCA balloon dilatation catheters - Mozec also CE marked Indian FDA approved.

Beyond these cardiovascular devices, you will soon see the launch of our peripheral angioplasty range from Stents to PTA balloons and then our own Percutaneous Aortic Valve.

Do kindly spare time to visit www.merillife.com and keep watching this space for newer thoughts to be introduced in this fast paced, rapidly changing industry.